Ocera Therapeutics, Inc.
OCRX
OCRX was delisted on the 8th of December, 2017.
36 hedge funds and large institutions have $19.2M invested in Ocera Therapeutics, Inc. in 2016 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 13 increasing their positions, 5 reducing their positions, and 3 closing their positions.
167% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 3
160% more repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 5
16% more funds holding
Funds holding: 31 → 36 (+5)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
10% less capital invested
Capital invested by funds: $21.3M → $19.2M (-$2.03M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VMI
VHCP Management II
New York
|
+$302K |
| 2 |
ECM
Endurant Capital Management
San Mateo,
California
|
+$288K |
| 3 |
VM
VHCP Management
New York
|
+$130K |
| 4 |
VKH
Virtu KCG Holdings
New York
|
+$100K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$81.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$599K |
| 2 |
Millennium Management
New York
|
-$458K |
| 3 |
TI
Turner Investments
Berwyn,
Pennsylvania
|
-$355K |
| 4 |
SM
Sabby Management
Miami Beach,
Florida
|
-$167K |
| 5 |
QF
QVT Financial
New York
|
-$60.2K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Northern Trust
Chicago,
Illinois
| $28K | +$1.24K | +532 | +4% |
|
27
Royal Bank of Canada
Toronto,
Ontario, Canada
| $28K | +$23.3K | +10,000 | +308% |
|
|
IIA
28
IPG Investment Advisors
San Diego,
California
| $27.3K | +$30.3K | +13,000 | New |
|
|
PAM
29
Panagora Asset Management
Boston,
Massachusetts
| $19K | – | – | – |
|
|
BIM
30
BlackRock Investment Management
Wilmington,
Delaware
| $6K | – | – | – |
|
31
Morgan Stanley
New York
| $5K | +$2.27K | +971 | +74% |
|
32
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
| $4K | – | – | – |
|
33
Creative Planning
Overland Park,
Kansas
| $3K | +$3.5K | +1,500 | New |
|
|
TRCT
34
Tower Research Capital (TRC)
New York
| $1K | +$700 | +300 | +75% |
|
|
AIM
35
Acrospire Investment Management
Chicago,
Illinois
| $1K | +$1.63K | +700 | New |
|
|
TI
36
Turner Investments
Berwyn,
Pennsylvania
| – | -$355K | -134,419 | Closed |
|
37
Bank of America
Charlotte,
North Carolina
| – | -$1K | -495 | Closed |
|
38
JP Morgan Chase
New York
| – | -$1K | -400 | Closed |
|
|
RFA
39
Reilly Financial Advisors
La Mesa,
California
| – | +$467 | +200 | New |
|
OCRX Hedge Fund Activity: Q4 2016 in Review
36 of the 4,001 institutional investors tracked by Wall St. Rank reported a position in Ocera Therapeutics, Inc. (OCRX) for Q4 2016, worth a combined $19.2M — down 9.5% from $21.3M a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new OCRX positions and 3 closed out — a net gain of 5 holders — while 13 added to existing stakes and 5 trimmed.
The largest buyer was VHCP Management II, adding an estimated $302K. The largest seller was Vanguard Group, cutting an estimated $599K.
- 36 institutional investors held Ocera Therapeutics, Inc. (OCRX) as of Q4 2016, up from 31 in Q3 2016.
- Funds reported $19.2M of Ocera Therapeutics, Inc. stock for Q4 2016, down 9.5% quarter-over-quarter.
- 8 funds opened new Ocera Therapeutics, Inc. positions in Q4 2016 and 3 closed out, a net change of +5 holders.
- The largest Ocera Therapeutics, Inc. buyer in Q4 2016 was VHCP Management II, an estimated $302K added.
- The largest Ocera Therapeutics, Inc. seller in Q4 2016 was Vanguard Group, an estimated $599K sold.
Based on aggregated 13F filings for Q4 2016.